Navigating the Maze of Diversity in Clinical Trials

Apr 23, 2024 - 11am EST

Online

As the landscape of clinical research evolves, the importance of inclusivity and diversity in clinical trials has never been more paramount. Join us to gain comprehensive insights and implications for diversity action plans in clinical trials.

Navigating the Maze of Diversity in Clinical Trials: Understanding and Implementing FDA Guidances

As the landscape of clinical research evolves, the importance of inclusivity and diversity in clinical trials has never been more paramount. Citeline, along with very special guests, aim to provide comprehensive insights and implications for diversity action plans in clinical trials. This informative webinar delves into the complexities and nuances of the latest FDA guidances on collecting race and ethnicity data in clinical trials.

Key points covered during this webinar include:

Strategies for Protocol Planning: Learn how to integrate diversity considerations into clinical trial designs from the ground up. We will discuss methods for creating protocols that are inclusive and representative of diverse populations.
Patient Engagement and Recruitment: Tackling the challenges of engaging and recruiting a diverse participant pool. The session will provide practical tactics for overcoming barriers to participation and ensuring that trials are accessible to underrepresented groups.
Data-Driven Approaches and Real-World Data (RWD): Discover how to leverage data analytics and real-world data to inform diversity strategies in clinical trials.
Implications of the FDA Webinar: Understanding its objectives and requirements for diversity action plans in clinical trials. We will explore how this act aligns with broader equity and inclusion goals in clinical trials and cover diversity components of the FDORA 2022 Act.
FDA Guidance on Race and Ethnicity Data Collection: An in-depth analysis of the FDA's guidelines for collecting and reporting race and ethnicity data. We'll discuss best practices for ensuring compliance and the significance of this data in enhancing trial outcomes.
Interactive Q&A Session: The webinar will conclude with an interactive session, allowing attendees to pose questions and discuss challenges they face in implementing these guidelines and practices.